Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin-Reference-Cited by-同舟云学术

Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin

Published:2021-01-21 Issue:8 Volume:12 Page:1395-1399
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Miya Aika¹^ORCID,Nakamura Akinobu¹^ORCID,Cho Kyu Yong¹²^ORCID,Kawata Shinichiro¹,Nomoto Hiroshi¹,Nagai So³,Sugawara Hajime⁴,Taneda Shinji⁵,Tsuchida Kazuhisa¹^ORCID,Omori Kazuno¹,Yokoyama Hiroki⁶^ORCID,Takeuchi Jun⁷,Aoki Shin⁸,Kurihara Yoshio⁹,Atsumi Tatsuya¹^ORCID,Miyoshi Hideaki¹¹⁰^ORCID

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

3. Division of Diabetes and Endocrinology Department of Medicine NTT Sapporo Medical Center Sapporo Japan

4. Third Department of Internal Medicine Hokkaido P.W.F.A.C Obihiro‐Kosei General Hospital Obihiro Japan

5. Department of Diabetes Centre Manda Memorial Hospital Sapporo Japan

6. Department of Internal Medicine Jiyugaoka Medical Clinic Obihiro Japan

7. Sapporo Diabetes and Thyroid Clinic Sapporo Japan

8. Aoki Clinic Sapporo Japan

9. Kurihara Clinic Sapporo Japan

10. Division of Diabetes and Obesity Faculty of Medicine and Graduate School of Medicine Hokkaido University Graduate School of Medicine Sapporo Japan

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13479

Reference15 articles.

1. Hypo- and Hyperglycemia in Relation to the Mean, Standard Deviation, Coefficient of Variation, and Nature of the Glucose Distribution

2. Metrics for glycaemic control — from HbA1c to continuous glucose monitoring

3. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes

4. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment

5. Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study;Journal of Diabetes Research;2022-01-19